Clinical Trial Update: Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the efficacy and safety of everolimus in combination therapy for HER2-overexpressing metastatic breast cancer; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Metastatic Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-03-31